# US 2025/0154576 A1 · Genotyping of targeted loci with single-cell chromatin accessibility

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154576 A1
- Document ID: US20250154576A1
- Status: Published application
- Kind: A1
- Application number: 18/719,752
- Filed: 2022-12-13
- Published: 2025-05-15
- Earliest claimed: 2021-12-13
- Assignees: Cornell University; New York Genome Center, Inc.
- Applicants: Cornell University; New York Genome Center, Inc.
- Inventors: Dan-Avi Landau; Robert Myers; Franco Izzo; Ronan Chaligne; Peter Smibert; Eleni Mimitou
- Web page: https://patentgrep.com/patent/US20250154576A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C12Q 1/6853: using modified primers or templates
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present disclosure relates generally to methods, compositions, and systems for processing nucleic acids from individual cells or cell populations. The present invention enables direct sequencing of full-length RNA molecules with no amplification steps. The present invention allows determination of RNA modifications in highly specific cell populations of any tissue.

## Claims

### Claim 1

A method of genotyping a locus, comprising:
generating a plurality of biological particles, each biological particle comprising a polynucleotide;
generating a plurality of partitions, each partition comprising one of the plurality of biological particles, a primer pair, and a barcoded bead; and
wherein the primer pair comprises:
a 5′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 3′ end of a locus within the polynucleotide, and
a 3′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 5′ end of the locus,
wherein the biological particle comprises genomic DNA and chromatin, and the genomic DNA is fragmented by a transposase to generate the plurality of genomic DNA fragments.

### Claim at position 2

2-3. (canceled)

### Claim 4 (depends on 1)

The method of claim 1, further comprising amplifying the locus using the primer pair to generate a locus nucleic acid fragment.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The method of claim 1, wherein the 5′ end of the 5′ primer-adapter nucleic acid molecule further comprises an adapter sequence.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein the 5′ end of the 3′ primer-adapter nucleic acid molecule further comprises a second adapter sequence.

### Claim 9

(canceled)

### Claim 10 (depends on 4)

The method of claim 4, wherein the locus nucleic acid fragment further comprises a sequence complementary to the Read 1 Nextera sequence.

### Claim 11 (depends on 1)

The method of claim 1, wherein the barcoded bead is attached to a nucleic acid.

### Claim at position 11

12-15. (canceled)

### Claim 16 (depends on 11)

The method of claim 11, wherein the nucleic acid attached to the barcoded bead further comprises a functional sequence configured to attach to a flow cell of a sequencer.

### Claim 17

(canceled)

### Claim 18 (depends on 16)

The method of claim 16, further comprising amplifying the locus nucleic acid fragment, or a derivative thereof, using a second primer pair comprising:
a 3′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 5′ end of the locus, and
a 5′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to functional sequence,
thereby generating a plurality of barcoded locus nucleic acid fragments, each fragment of the plurality of barcoded locus nucleic acid fragments comprising the locus.

### Claim 19 (depends on 16)

The method of claim 16, further comprising amplifying the locus nucleic acid fragment, or a derivative thereof, using a third primer pair comprising:
a 5′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 3′ end of the locus, and
a 3′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to functional sequence,
thereby generating a plurality of barcoded locus nucleic acid fragments, each fragment of the plurality of barcoded locus nucleic acid fragments comprising the locus.

### Claim at position 16

20-27. (canceled)

### Claim 28 (depends on 1)

The method of claim 1, wherein the transposase is fused to a set of secondary nanobodies (nb).

### Claim 29 (depends on 28)

The method of claim 28, wherein a primary antibody is bound to a target of interest on the chromatin.

### Claim 30 (depends on 28)

The method of claim 28, wherein the transposase-nb fusion protein specifically binds to primary antibody.

### Claim 31 (depends on 1)

The method of claim 1, wherein the transposase is a Tn5 transposase.

### Claim 32 (depends on 1)

The method of claim 1, wherein the genomic DNA is fragmented by a transposase-nucleic acid complex to generate a plurality of tagged genomic DNA fragments.

### Claim 33 (depends on 32)

The method of claim 32, wherein the 5′ end of each of the tagged genomic DNA fragments comprises an adapter sequence.

### Claim 34 (depends on 32)

The method of claim 32, wherein the 3′ end of each of the tagged genomic DNA fragments comprises a second adapter sequence.

### Claim at position 24

35-36. (canceled)

### Claim 37 (depends on 24)

The method of claim 24, further comprising amplifying the plurality of genomic DNA fragments, or derivatives thereof, by nucleic acid amplification generating a plurality of barcoded genomic DNA fragments.

### Claim at position 26

38-42. (canceled)

### Claim 43 (depends on 18)

The method of claim 18, further comprising amplifying the barcoded locus nucleic acid fragments, or derivatives thereof, by nucleic acid amplification.

### Claim at position 28

44-64. (canceled)

### Claim 65

A partition comprising: a biological particle comprising a polynucleotide, a primer pair, and a barcoded bead; and
wherein the primer pair comprises:
a 5′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 3′ end of a locus within the polynucleotide, and
a 3′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 5′ end of the locus.

### Claim at position 30

66-103. (canceled)

### Claim 104

A kit comprising partitioning fluid, a barcoded bead, and a primer pair comprising:
a 5′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 3′ end of a specific locus within a polynucleotide, and
a 3′ primer-adapter nucleic acid molecule comprising a nucleotide sequence that is complementary to a sequence located at the 5′ end of the specific locus.

### Claim at position 32

105-116. (canceled)
